报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 0.72% | -87.07% | 348.28% | 107/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
2024-06-30 | -0.29% | -106.64% | -196.67% | 116/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
2024-03-31 | 0.3% | -88.89% | -93.59% | 110/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
2023-12-31 | 4.68% | -57.49% | -15.98% | 65/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
2023-09-30 | 5.57% | -35.9% | 27.46% | 62/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
2023-06-30 | 4.37% | -34.09% | 61.85% | 51/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
2023-03-31 | 2.7% | -48.37% | -75.48% | 44/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
2022-12-31 | 11.01% | -34.85% | 26.7% | 39/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
2022-09-30 | 8.69% | 2% | 31.07% | 39/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
2022-06-30 | 6.63% | -29.99% | 26.77% | 31/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
2022-03-31 | 5.23% | 2% | -69.05% | 13/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
2021-12-31 | 16.9% | -24.96% | 78.46% | 16/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
2021-06-30 | 9.47% | -36.14% | -57.95% | 18/160 | 2.99% | 小方制药 | 71.99% | 行业排名> |
2020-12-31 | 22.52% | -19.94% | 51.85% | 15/160 | 3.74% | 汇宇制药 | 39.25% | 行业排名> |
2020-06-30 | 14.83% | 21.46% | -47.28% | 8/160 | 4.24% | 汇宇制药 | 28.14% | 行业排名> |
2019-12-31 | 28.13% | 20.68% | 20.68% | 7/160 | 2.78% | 哈三联 | 27.17% | 行业排名> |
2018-12-31 | 23.31% | 7.82% | 90.91% | 7/160 | 7.09% | 汇宇制药 | 55.94% | 行业排名> |
2018-06-30 | 12.21% | 0.66% | -43.52% | 7/160 | 4.65% | 河化股份 | 45.32% | 行业排名> |
2017-12-31 | 21.62% | 2% | 78.24% | 10/160 | 9.66% | 汇宇制药 | 31.9% | 行业排名> |
2017-06-30 | 12.13% | 2% | 2% | 7/160 | 5.59% | 誉衡药业 | 35.56% | 行业排名> |